Methods of accelerated atherosclerosis in diabetic patients

被引:45
|
作者
Pasterkamp, Gerard [1 ]
机构
[1] Univ Med Ctr Utrecht, Lab Expt Cardiol, Dept Cardiol, NL-3584 CX Utrecht, Netherlands
关键词
RISK; GLUCOSE; PLAQUES; DISEASE; PATHOPHYSIOLOGY; MELLITUS; STROKE; HEART;
D O I
10.1136/heartjnl-2011-301172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic patients have an increased risk of cardiovascular disease (CVD), which is a major contributor to morbidity and mortality in the aging population, and have a more than twofold increase in the risk of dying from CVD.1 Even patients with pre-diabetes, as detected by abnormal glucose tolerance tests, have an increased risk of developing disabling stroke, peripheral artery disease, and myocardial infarction. Healthcare spending for people with diabetes is more than double the expenditure on those without diabetes, and a significant part of these costs is explained by CVD comorbidity. This article will focus on the effect of diabetes on the initiation and progression of arterial occlusive disease, preceded by a short outline of the enormous impact of this issue from a societal-economic perspective.
引用
收藏
页码:743 / 749
页数:7
相关论文
共 50 条
  • [21] Role of the Scavenger Receptor CD36 in Accelerated Diabetic Atherosclerosis
    Navas-Madronal, Miquel
    Castelblanco, Esmeralda
    Camacho, Mercedes
    Consegal, Marta
    Ramirez-Morros, Anna
    Rosa Sarrias, Maria
    Perez, Paulina
    Alonso, Nuria
    Galan, Maria
    Mauricio, Didac
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 19
  • [22] A murine model of accelerated atherosclerosis in diabetic LDL receptor deficient mice
    Lee, KJ
    Lu, Y
    Ginsberg, MD
    Ferran, L
    Stern, DM
    Schmidt, AM
    CIRCULATION, 1997, 96 (08) : 968 - 968
  • [23] Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
    Park', L
    Raman, KG
    Lee, KJ
    Lu, Y
    Ferran, LJ
    Chow, WS
    Stern, D
    Schmidt, AM
    NATURE MEDICINE, 1998, 4 (09) : 1025 - 1031
  • [24] Diabetic mice overexpressing human apo B demonstrate accelerated atherosclerosis
    Tsai, M
    Ruman, KG
    Lu, Y
    Ferran, LJ
    Chow, WS
    Berglund, LS
    Huang, LS
    Schmidt, AM
    PEDIATRIC RESEARCH, 1999, 45 (04) : 99A - 99A
  • [25] A murine model of accelerated diabetic atherosclerosis with minimal modification of lipid profile
    Makker, G
    Lee, K
    Fan, L
    Lindenberg, N
    Lu, Y
    Chow, WS
    Schmidt, AM
    FASEB JOURNAL, 1998, 12 (04): : A481 - A481
  • [26] Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
    Lisa Park
    Kathleen G. Raman
    Kenneth J. Lee
    Yan Lu
    Luis J. Ferran
    Wing Sun Chow
    David Stern
    Ann Marie Schmidt
    Nature Medicine, 1998, 4 : 1025 - 1031
  • [27] Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients
    Augoulea, Areti
    Vrachnis, Nikolaos
    Lambrinoudaki, Irene
    Dafopoulos, Konstantinos
    Iliodromiti, Zoe
    Daniilidis, Angelos
    Varras, Michail
    Alexandrou, Andreas
    Deligeoroglou, Efthymios
    Creatsas, George
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [28] ATHEROSCLEROSIS AND INCIPIENT NEPHROPATHY IN DIABETIC PATIENTS
    Nelaj, Ergita
    Kecaj, Irida
    Gjata, Margarita
    Tase, Mihal
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E190 - E190
  • [29] ATHEROSCLEROSIS AND INCIPIENT NEPHROPATHY IN DIABETIC PATIENTS
    Nelaj, Ergita
    Kecaj, Irida
    Gjata, Margarita
    Tase, Mihal
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E190 - E190
  • [30] Atherosclerosis and oxidative stress in diabetic patients
    Soska, V
    Lojek, A
    Hlozkova, P
    Olsovsky, J
    Zechmeister, A
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 207 - 207